The prevalence of myopia is much higher than hyperopia. Hence, there are relatively few studies investigating phakic intraocular lens (pIOL) implantation for the correction of hyperopia. This review aimed to summarize the available relevant literature on the efficacy and safety of pIOL implantation for the correction of hyperopia and hyperopic astigmatism. At present, two types of pIOLs are used to correct hyperopia and hyperopic astigmatism: anterior chamber iris-fixated pIOLs and posterior chamber implantable collamer lenses. Both have been found to be safe and effective. No serious events (eg, retinal or choroidal detachment, endophthalmitis) were reported in the reviewed articles. Implantation of pIOLs might be the optimal refractive surgery for the correction of high hyperopia.

中文翻译：

---

晶状体人工晶状体植入术可矫正远视。

近视的患病率远高于远视。因此，很少有研究调查有晶状体人工晶状体（pIOL）植入术以矫正远视。这篇综述旨在总结有关pIOL植入治疗远视和远视散光的有效性和安全性的相关文献。目前，有两种类型的pIOL用于矫正远视和远视散光：前房虹膜固定型pIOL和后房可植入式散光镜。两者都被发现是安全有效的。综述文章中未报告严重事件（例如视网膜或脉络膜脱离，眼内炎）。植入pIOL可能是矫正高度远视的最佳屈光手术。